Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PCVX - Vaxcyte, Inc.
640 M
LAST VALUE
499.61%
2 YEAR CAGR
59.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR